|
OIG: Many FDAers Still Wary to Air Concerns, Unclear on Dispute Process
The number of internal scientific disagreements over device approvals has waned since late 2009, when the FDA implemented new procedures for handling such disputes, but many employees are still hesitant to raise scientific concerns with agency management, according to a new report by the HHS Office of Inspector General.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives